Walvax Biotechnology Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,230
584
1,060
1,423
1,211
2,484
Total Accounts Receivable
962
1,442
1,098
897
747
1,381
Inventories
368
156
145
155
211
236
Other Current Assets
130
50
64
556
78
37
Total Current Assets
2,690
2,232
2,367
3,032
2,247
4,139
Net Property, Plant & Equipment
1,233
1,287
1,396
1,431
1,567
1,363
Total Investments and Advances
118
595
728
366
357
784
Long-Term Note Receivable
-
-
27
-
-
-
Intangible Assets
2,058
1,743
1,642
1,369
1,557
861
Other Assets
6
52
43
75
105
45
Total Assets
6,136
5,979
6,258
6,324
5,876
7,237
ST Debt & Current Portion LT Debt
1,176
1,036
1,387
693
244
Accounts Payable
156
161
213
152
213
Income Tax Payable
21
24
11
3
7
Other Current Liabilities
525
205
576
1,134
1,011
Total Current Liabilities
1,878
1,427
2,187
1,981
1,475
Long-Term Debt
988
991
595
380
256
Deferred Taxes
225
170
182
164
138
Other Liabilities
-
-
-
-
160
Total Liabilities
3,123
2,658
3,020
2,577
2,073
Common Equity (Total)
2,743
2,883
2,285
3,207
3,027
Total Shareholders' Equity
2,743
2,883
2,285
3,207
3,027
Total Equity
2,938
3,212
3,024
3,524
3,557
Liabilities & Shareholders' Equity
6,136
5,979
6,258
6,324
5,876
Accumulated Minority Interest
196
329
739
316
530
Non-Equity Reserves
75
109
214
224
245
About Walvax Biotechnology Co.
View Profile
